Timothy Chao
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Background Spindle epithelial tumors with thymus‐like differentiation (SETTLE) and carcinomas showing thymus‐like differentiation (CASTLE) are rare intrathyroid tumors. Methods This retrospective cohort study included patients diagnosed with SETTLE, CASTLE, and papillary thyroid carcinoma (PTC) from 2004 to 2020 within the National Cancer Database (NCDB). Demographic, tumor, and treatment characteristics were compared. Overall survival (OS) was analyzed using the Kaplan–Meier method and Cox regression models. Results This study identified 19 patients with CASTLE, 11 with SETTLE, and 483 474 with PTC. CASTLE and SETTLE patients had larger tumors, lymphovascular invasion, and positive surgical margins. They were rarely treated with radioactive iodine treatment but frequently received external beam radiation and chemotherapy. Five‐year OS was significantly lower for CASTLE and SETTLE compared to PTC. SETTLE was associated with an increased risk of death. Conclusion SETTLE and CASTLE are rare intrathyroid tumors with worse survival compared to PTC, often managed with radiation, chemotherapy, and surgery.
Year:
2025
Objectives Functional dyspepsia (FD) is a disorder of the gut–brain interaction characterized by epigastric pain, nausea, and/or early satiety. Existing literature suggests a physical link between psychiatric diagnoses and disorders of the gut–brain interaction at intestinal mast cells (MC) via corticotropin‐releasing hormone (CRH) and its intestinally located receptors (CRHR1/CRHR2). Our study aimed to further clarify the physiologic connection between pediatric psychiatric illness and FD. Methods Study subjects were identified and classified into three groups. The FD group met Rome IV criteria and had insignificant gross endoscopic and histologic findings on gastric and duodenal biopsies. The control group reported no gastrointestinal symptoms or documented psychiatric illness. A third group consisted of Helicobacter pylor i (HP)‐positive dyspepsia patients independent of psychiatric history. Duodenal biopsy blocks were stained with antibodies targeting MCs, CRH, and CRHR1/CRHR2. Results We included 49 patients: 21 FD, nine controls, and 19 HP patients. We found a statistical difference between duodenal MC density in FD versus controls and HP versus controls ( p < 0.05). We found no significant CRHR2 staining in the control group, yet the FD and HP groups yielded strong stains. We found a significant increase in MC density and CRHR2 staining in patients with a psychiatric history versus without ( p < 0.05). Conclusion Our data show increased MC density and stronger CRHR2 staining in patients with FD and in patients with a psychiatric history. Our data support a pathophysiologic theory of FD development via a “gut–brain axis” intersecting at the level of MCs with influence via peripheral CRH.
Year:
2025
Context.— Mutant KRAS is the main oncogenic driver in pancreatic ductal adenocarcinomas (PDACs). However, the clinical and phenotypic implications of harboring different mutant KRAS alleles remain poorly understood. Objective.— To characterize the potential morphologic and clinical outcome differences in PDACs harboring distinct mutant KRAS alleles. Design.— Cohort 1 consisted of 127 primary conventional PDACs with no neoadjuvant therapy, excluding colloid/mucinous, adenosquamous, undifferentiated, and intraductal papillary mucinous neoplasm–associated carcinomas, for which an in-house 42-gene mutational panel had been performed. A morphologic classification system was devised wherein each tumor was assigned as conventional, papillary/large duct (P+LD, defined as neoplastic glands with papillary structure and/or with length ≥0.5 mm), or poorly differentiated (when the aforementioned component was 60% or more of the tumor). Cohort 2 was a cohort of 88 PDACs in The Cancer Genome Atlas, which were similarly analyzed. Results.— In both cohorts, there was significant enrichment of P+LD morphology in PDACs with KRAS G12V and G12R compared with G12D. In the entire combined cohort, Kaplan-Meier analyses showed longer overall survival (OS) with KRAS G12R as compared with G12D (median OS of 1255 versus 682 days, P = .03) and in patients whose PDACs displayed P+LD morphology as compared with conventional morphology (median OS of 1175 versus 684 days, P = .04). In the adjuvant-only subset, KRAS G12R had the longest OS compared with G12D, G12V, and other alleles (median OS unreached/undefined versus 1009, 1129, and 1222 days, respectively). Conclusions.— PDACs with different mutant KRAS alleles are associated with distinct morphologies and clinical outcomes, with KRAS G12R allele associated with P+LD morphology and longer OS when compared with G12D using Kaplan-Meier studies.
Year:
2024
Year:
2023
Collaborators (2)
Zhaoping He
Assistant Research Professor
Thomas Jefferson University
Robert M. Brody
Assistant Professor
University of Pennsylvania
Make your next move.
Prepare your application
Review drafts before you send them.